openPR Logo
Press release

Phenylbutazone Market Trends Estimates High Demand by 2025

02-13-2018 07:38 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Phenylbutazone Market Trends Estimates High Demand by 2025

Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) for the short-term treatment of fever and pain in animals. In the UK and the U.S., it is no longer approved for human use, as it can cause severe adverse effects such as aplastic anemia and suppression of white blood cell production. Phenylbutazone was originally used in humans for the treatment of gout and rheumatoid arthritis in 1949. Phenylbutazone is commonly used in horses for the following purposes: Antipyresis and Analgesia.

Request to Sample of Report- https://www.persistencemarketresearch.com/samples/20644

Phenylbutazone is used for pain relief from musculoskeletal disorders including overuse injuries, sprains, tendinitis, arthralgias, laminitis and arthritis and relief from infection. Phenylbutazone acts directly on musculoskeletal tissue to control inflammation, thereby alleviating pain, and restoring range of motion. Phenylbutazone can be administered intravenously or orally (via powder, paste or feed-in). Phenylbutazone should not be injected in any place other than a vein and administered intramuscularly. Edema and tissue damage may also occur if the drug is injected repetitively into the same vein. Side effects of phenylbutazone include blood dyscrasia, GI ulcers, oral lesions, kidney damage and internal hemorrhage. Phenylbutazone should not be used in combination with vitamin K antagonists such as warfarin as it amplifies the anticoagulant effect of these drugs. Phenylbutazone displaces warfarin from toxic blood levels and plasma binding sites leading to haemorrhage.

The growth in end user industries is expected to increase demand for phenylbutazone. The growth in veterinary medicine industry is expected to increase consumption of phenylbutazone. In addition, rising demand for non steroidal anti-inflammatory drugs from emerging economies of Asia Pacific and Latin America is expected to boost demand for phenylbutazone. However, availability of substitutes and government regulations could hamper the growth of this market. Harpagophytum can replace phenylbutazone for treatment of fever and pain in horses.

Asia Pacific is expected to be the largest consumer of phenylbutazone followed by North America and Europe. China and India are the major consumers of phenylbutazone in Asia Pacific due to presence of established end user industries. Phenylbutazone manufacturers are shifting their base to emerging economies of Asia Pacific due to availability of government subsidies, land and cheap labor. Mongolia, Republic of Korea, Australia and New Zealand are expected to be other major consumers of phenylbutazone in Asia Pacific. North America and Europe are expected to experience moderate to high growth. In addition, demand for phenylbutazone is expected to increase in emerging economies of Latin America due to increasing demand for veterinary drugs. Argentina, Brazil, Colombia and Peru are major consumers of phenylbutazone in Latin America. The market is dominated by large and medium chemical and pharmaceutical corporations.

Request Report for TOC @ https://www.persistencemarketresearch.com/toc/20644

Some of the key players in this market are Santa Cruz Biotechnology, Inc. (U.S.), Hangzhou Hyper Chemicals Limited (China), Baoji Guokang Bio-Technology Co., Ltd.(China), Wuhan Yitongtai Science and Technology Co., Ltd. (China), Afine Chemicals Limited (china), Shanghai Win-Win Biochemical Co., Ltd. (china), Shaanxi TOP Pharm Chemical Co., Ltd.(China), Hangzhou Hyper Chemicals Limited (China), Hangzhou Ruijiang Chemical Co., Ltd. (China), Dalian Launcher Fine Chemical Co., Ltd.(China), Croma Life Science Pvt. Ltd (India), Swati Chemicals (India), Suchem Laboratories (India), Uni-med India (India), Afton Pharma (India) and Hefei TNJ Chemical Industry Co., Ltd. (China) among others. Companies are using strategic acquisitions and mergers to remain competitive in the market. In addition, companies are increasing their presence in emerging economies of Latin America and Europe to increase their market presence.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web:https://www.persistencemarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phenylbutazone Market Trends Estimates High Demand by 2025 here

News-ID: 940759 • Views: 185

More Releases from Persistence Market Research

The Outpatient Home Therapy Market to witness an overall with respect to growth …
Outpatient home therapy provides treatment at the patient’s home. There need for outpatient home therapy is growing and more facilities are added to the services. Outpatient home therapy provides extra comfort to the patients and is regulated by the Medicare and Medicaid programs. Home therapy is useful when patients are not able to travel to the healthcare units due to lack of transportation or the patient may not be able
The Meningococcal Vaccines Market to scale high in the next decade
The meningococcal vaccine market has expanded to a significant extent over the past few years in correspondence to the parent market. Constant research and development in meningococcal vaccines for various meningococcal disease preventive applications, coupled with the sanctions of subsidy & support of government organizations for immunization program are among the significant factors that are anticipated to drive the growth of the meningococcal vaccine market during the forecast period. Expansion of
The Immunoassay Interference Blocker Market to be on the escalation mode in the …
The rapidly increasing prevalence of chronic diseases and the growth of the aging population across the world are among factors that are expected to increase the need for biochemical testing for the management of chronic diseases. The global increase in aging population is expected to increase the demand for diagnostic kits and reagents for the detection of age-related as well as other chronic conditions, which is expected to boost the
The Orthopedic Surgical Robots Market to foresee growth in the next 10 years
Orthopedic surgical robots have gained immense popularity over the years. Consistent advancements in the technology for orthopedic surgical robots, the availability of orthopedic surgical robots across the globe, and increase in government funding and investments by manufacturers for the development of orthopedic surgical robots are among the primary factors that are anticipated to fuel the demand for orthopedic surgical robots during the forecast period. According to the latest research by PMR,

All 5 Releases


More Releases for Phenylbutazone

Phenylbutazone Market – Notable Developments, Upcoming Trends & Future Applica …
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone
Phenylbutazone Market In-depth Analysis Prophesy 2025
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone
Phenylbutazone Market Region-based Analysis by 2025
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone
Phenylbutazone Market - Geographical Perspective and Forecast 2017 - 2025
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone
Phenylbutazone Market - Leading Players In Industry & Forecast 2017 - 2025
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone
Phenylbutazone Market : Technological Development, Applications, Product, End Us …
Global Phenylbutazone Market: Snapshot The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone